Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, February 7, 2020
[ Fri, Feb 07th 2020
] - WOPRAI
[ Fri, Feb 07th 2020
] - WOPRAI
[ Fri, Feb 07th 2020
] - WOPRAI
[ Fri, Feb 07th 2020
] - WOPRAI
[ Fri, Feb 07th 2020
] - WOPRAI
[ Fri, Feb 07th 2020
] - WOPRAI
Thu, February 6, 2020
[ Thu, Feb 06th 2020
] - WOPRAI
[ Thu, Feb 06th 2020
] - WOPRAI
[ Thu, Feb 06th 2020
] - WOPRAI
[ Thu, Feb 06th 2020
] - WOPRAI
[ Thu, Feb 06th 2020
] - WOPRAI
[ Thu, Feb 06th 2020
] - WOPRAI
[ Thu, Feb 06th 2020
] - WOPRAI
[ Thu, Feb 06th 2020
] - WOPRAI
[ Thu, Feb 06th 2020
] - WOPRAI
[ Thu, Feb 06th 2020
] - WOPRAI
[ Thu, Feb 06th 2020
] - WOPRAI
[ Thu, Feb 06th 2020
] - WOPRAI
[ Thu, Feb 06th 2020
] - WOPRAI
[ Thu, Feb 06th 2020
] - WOPRAI
[ Thu, Feb 06th 2020
] - WOPRAI
[ Thu, Feb 06th 2020
] - WOPRAI
[ Thu, Feb 06th 2020
] - WOPRAI
[ Thu, Feb 06th 2020
] - WOPRAI
[ Thu, Feb 06th 2020
] - WOPRAI
[ Thu, Feb 06th 2020
] - WOPRAI
[ Thu, Feb 06th 2020
] - WOPRAI
[ Thu, Feb 06th 2020
] - WOPRAI
[ Thu, Feb 06th 2020
] - WOPRAI
Jay Olson Initiated (VYGR) at Buy and Held Target at $26 on, Feb 6th, 2020
Jay Olson of Oppenheimer, Initiated "Voyager Therapeutics, Inc." (VYGR) at Buy and Held Target at $26 on, Feb 6th, 2020.
Jay has made no other calls on VYGR in the last 4 months.
There is 1 other peer that has a rating on VYGR. Out of the 1 peers that are also analyzing VYGR, all agrees with Jay's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jeffrey Hung of "Morgan Stanley" Maintained at Hold with Decreased Target to $26 on, Friday, October 11th, 2019
